Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement

Ferrini, Rebecca; Mannino, Elizabeth; Ramsdell, Edith; Hill, Linda

doi:10.1016/s0749-3797(18)30289-7

Cited by 57 publications

(29 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The US Preventive Services Task Force, for example, following a review of published literature on breast cancer screening, 16,17 concluded that the evidence is insufficient to recommend for or against routine CBE alone to screen for breast cancer. The American College of Preventive Medicine, 18 the American College of Physicians, 19 and American Association of Family Practitioners 20 do not address CBE in their breast cancer screening statements.…”

Section: The Clinical Breast Examination's (Cbe's) Contributions To Tmentioning

confidence: 99%

Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting

Saslow

Hannan

Osuch

et al. 2004

CA: A Cancer Journal for Clinicians

137

102

View full text Add to dashboard Cite

Clinical breast examination (CBE) seeks to detect breast abnormalities or evaluate patient reports of symptoms to find palpable breast cancers at an earlier stage of progression.Treatment options for earlier-stage cancers are generally more numerous, include less toxic alternatives, and are usually more effective than treatments for later-stage cancers. For average-risk women aged 40 and younger, earlier detection of palpable tumors identified by CBE can lead to earlier therapy. After age 40, when mammography is recommended, CBE is regarded as an adjunct to mammography. Recent debate, however, has questioned the contributions of CBE to the detection of breast cancer in asymptomatic women and particularly to improved survival and reduced mortality rates. Clinicians remain widely divided about the level of evidence supporting CBE and their confidence in the examination. Yet, CBE is practiced extensively in the United States and continues to be recommended by many leading health organizations. It is in this context that this report provides a brief review of evidence for CBE's role in the earlier detection of breast cancer, highlights current practice issues, and presents recommendations that, when implemented, could contribute to greater standardization of the practice and reporting of CBE. These recommendations may also lead to improved evidence of the nature and extent of CBE's contribution to the earlier detection of breast cancer. (CA Cancer

show abstract

Section: The Clinical Breast Examination's (Cbe's) Contributions To Tmentioning

confidence: 99%

Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting

Saslow

Hannan

Osuch

et al. 2004

CA: A Cancer Journal for Clinicians

137

102

View full text Add to dashboard Cite

show abstract

“…There are many imaging methods available to detect BC such as ultrasonography, MRI and scinti-mammography (Tc 99m Sestamibi) with variable degrees of sensitivity, but mammography remains the most widely used method up to date, with a sensitivity ranging from 75% to 90% and specificity from 90% to 95% 9 .…”

Section: Introductionmentioning

confidence: 99%

Demographic, Clinical and Mammographic Characteristics of Invasive Ductal Carcinoma of the Breast; A Sri Lankan Experience

Perera

Hettiarachchi

Ratnatunga

et al. 2016

Sri Lanka J. Radiol.

View full text Add to dashboard Cite

Breast cancer (BC) ranks the highest among all cancers of women worldwide. Mammography is the most widely utilized imaging tool for evaluation of breast cancer with the final diagnosis being made on histopathology. This study aimed at describing the demographic, clinical and mammographic characteristics of histologically proven invasive ductal carcinoma (IDC) of breast in a group of Sri Lankan women. The study was carried out using a database on mammography maintained by the principal investigator. Study sample consisted of 177 subjects. The mean age of subjects was 52.2 years (SD ± 1.1). Majority (63.8%) were postmenopausalwomen. 93% of them presented with symptomatic breast disease, and the commonest symptom was a palpable mass (90.7%). Presentation for mammography after observing symptoms showed a median delay of 28 days. BC was found mostly in involuting type of breasts. Commonest mammography characteristic was a mass (86.4%). Size of the mass was between 2 cm to 5 cm in majority (84.3%) with T stage II disease. In conclusion, mean age of the subjects was comparable to other Asian countries but relatively lower than that of the west. Majority of patients presented with a palpable mass within four weeks from the onset of symptoms. The size of the mass did not show a significant correlation with the duration of symptoms and the age. This study did not find a significant association between mammographic breast density with IDC.

show abstract

“…33 Researchers have suggested that mortality in women aged 50-69 years might be reduced 20%-35% through use of mammographic screening, 34 and a small qualitative study reported that women overwhelmingly saw mammography as beneficial. 35 Although controversy over appropriate use of the technique exists, numerous organizations [36][37][38][39][40][41][42][43] have recommended routine mammography for women, beginning at 40 or 50 years, with at least biennial frequency. Despite considerable support for mammographic screening, however, two studies reported declining use of the procedure between 1999 and 2005.…”

mentioning

confidence: 99%

Preventive Screening of Women Who Use Complementary and Alternative Medicine Providers

Downey

Tyree

Lafferty

2009

Journal of Women's Health

View full text Add to dashboard Cite

Background: Many women use complementary and alternative medicine (CAM). Although CAM use has been associated with reductions in conventionally recommended pediatric preventive care (e.g., vaccination), little is known about associations between CAM use and receipt of recommended preventive screening in women. Methods: Using Washington State insurance data from 2000 to 2003, the authors generated clustered logistic regression models, examining associations between provider-based CAM use and receipt of screening tests for Chlamydia trachomatis, breast cancer, and cervical cancer: (1) contrasting women who used CAM providers only (alternative use) and women who used both conventional and CAM providers (complementary use) with women who used conventional care only and (2) testing associations between screening and use of four specific CAM provider types-naturopathic physicians, chiropractors, massage therapists, and acupuncturists. Results: Both alternative and complementary use was associated with reduced Chlamydia screening. Cancer screening increased with complementary use but decreased with alternative use of CAM. Use of naturopathy was associated with decreased mammography, whereas all four CAM therapies were positively associated with Papanicolaou testing. Conclusions: When used in conjunction with conventional care, use of provider-based CAM may signal high interest in various types of health-promoting behavior, including cancer screening. Negative associations between CAM and Chlamydia screening and between naturopathy and mammography require additional study. Interventions with CAM providers and their patients, aimed at improving rates of conventionally recommended screening, might encourage greater focus on preventive care, an important task when CAM providers serve as women's only contact with the healthcare system.

show abstract

Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement

Cited by 57 publications

References 7 publications

Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting

Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting

Demographic, Clinical and Mammographic Characteristics of Invasive Ductal Carcinoma of the Breast; A Sri Lankan Experience

Preventive Screening of Women Who Use Complementary and Alternative Medicine Providers

Contact Info

Product

Resources

About